{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T13:30:21Z","timestamp":1793539821204,"version":"4.5.0"},"reference-count":0,"publisher":"The Journal of Rheumatology","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate national prevalence of opioid use, including chronic and high-risk use, among older adults with rheumatic diseases (RDs); to identify sociodemographic and clinical factors associated with chronic opioid use; and to characterize prescribing patterns by clinician specialty in a contemporary Medicare-linked national registry cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a cross-sectional analysis of the Rheumatology Informatics System for Effectiveness (RISE) registry linked to Medicare Part D (2016-2021). Patients were aged \u2265 65 years with qualifying RDs and continuous Medicare enrollment in 2021. Opioid use was identified from Part D claims. Chronic use was defined as \u2265 90-day supply in 2021. High-risk use was assessed using Office of Inspector General indicators. Generalized estimating equations modeled factors associated with chronic opioid use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 45,455 patients (mean age 75.8 years; 76.88% women), 43.13% filled \u2265 1 opioid prescription and 17.93% met criteria for chronic use in 2021. Very high-risk prescribing was rare (&lt; 1%). Chronic use was most prevalent in axial spondyloarthritis (axSpA; 26.19%) and least prevalent in polymyalgia rheumatica (11.58%). In adjusted analyses, axSpA (odds ratio [OR] 1.63, 95% CI 1.35-1.98), fibromyalgia (OR 2.68, 95% CI 2.39-3.00), mood disorder (OR 1.41, 95% CI 1.31-1.52), anxiety disorder (OR 1.46, 95% CI 1.35-1.57), higher comorbidity burden (OR 1.82, 95% CI 1.62-2.06), American Indian\/Alaska Native race (OR 1.64, 95% CI 1.09-2.45), and greater socioeconomic deprivation (OR 1.91, 95% CI 1.71-2.13) were independently associated with chronic use. Nonrheumatology clinicians wrote most opioid prescriptions (62.60%) and more high-dose prescriptions (\u2265 50 morphine mg equivalents\/day).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Opioid exposure remains common among Medicare-insured older adults with RDs, although very high-risk prescribing is rare. Coordinated, guideline-concordant pain management across specialties may help preserve appropriate opioid use for patients who may benefit while reducing avoidable long-term exposure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2026-0220","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:20:20Z","timestamp":1792066820000},"page":"jrheum.2026-0220","source":"Crossref","is-referenced-by-count":0,"title":["Persistent Opioid Exposure in Older Adults With Rheumatic Disease: National Patterns, Disparities, and Cross-Specialty Prescribing"],"prefix":"10.3899","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3074-2529","authenticated-orcid":false,"given":"Christine","family":"Anastasiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8435-8994","authenticated-orcid":false,"given":"Eric","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-5477","authenticated-orcid":false,"given":"Daniel","family":"Ciccarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8972-9388","authenticated-orcid":false,"given":"Karen","family":"Costenbader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2687-5043","authenticated-orcid":false,"given":"Gabriela","family":"Schmajuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3508-4094","authenticated-orcid":false,"given":"Jinoos","family":"Yazdany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2026,10,15]]},"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2026-0220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T13:25:24Z","timestamp":1793539524000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2026-0220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":0,"alternative-id":["10.3899\/jrheum.2026-0220"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2026-0220","relation":{},"ISSN":["0315-162X","1499-2752","0315-162X"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"},{"value":"0315-162X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}